Provided by Tiger Fintech (Singapore) Pte. Ltd.

PHARMARON

15.300
+0.1000.66%
Volume:3.28M
Turnover:50.13M
Market Cap:27.10B
PE:13.81
High:15.400
Open:15.400
Low:15.140
Close:15.200
Loading ...

HK Movers | HK's Biotech Shares Soar. JOINN Soars 8%; Fudan-Zhangjiang up 6%; HeartCare up 2%

Tiger Newspress
·
17 Jun

HK Movers | Biotech Stocks Jump. Canbridge Soars 40%; Ascletis Jumps 17%; TYK Medicines Gains 7%; HBM Holdings, Abbisko Up More Than 6%

Tiger Newspress
·
16 Jun

China's Biotech Moment Ignites a 60% Stock Rally That Beats AI

Bloomberg
·
15 Jun

HK Movers|Pharma Shares Rallied. Sino Biopharm Up 13%; Immunothech And Zai Lab Up 5%; Dualitybio And Grand Pharmaup 4%

Tiger Newspress
·
12 Jun

HK Movers|Pharma Shares Rallied. CSPC Pharma Up 9%; 3SBio Up 4%; Yihai Up 3%; Genscript Bio And JXR Up 2%.

Tiger Newspress
·
06 Jun

HK Movers|HK Pharma Shares Kept Rally. Zai Lab Up 7%; Hutchmed Up 6%; Immunotech Up 5%

Tiger Newspress
·
05 Jun

HK Movers|Pharma Shares Jumped. Innovent Bio Up 15%; Zai Lab Up 5%; Junshi Bio And CSPC Pharma Up 4%

Tiger Newspress
·
04 Jun

HK Movers|HK's Pharma Shares Jumped. Medlive Up 8%; Sihuan Pharm And Junshi Bio Up 7%; Pharmaron And Fosun Pharma Up 5%

Tiger Newspress
·
03 Jun

HK Movers | HK's Biotech Shares Soar. Asymchem up 15%; Laekna up 13%; Ascletis, CanSinoBIO up 9%

Tiger Newspress
·
21 May

HK Movers | HK's Biotech Shares Soar. Cstone Pharma Soars 20%; RemeGen up 10%; Ascletis up 6%

Tiger Newspress
·
20 May

HK Movers | HK's Biotech Shares Pull Back. Alphamab, Cstone Pharma, Ascletis down about 10%; Immuneonco, Laekna down over 9%

Tiger Newspress
·
12 May

HK Movers|HK Pharma Stocks Shined. Ascletis up 18%; Dualitybio up 8%; Zai Lab, HBM and Remegen Up 6%.

Tiger Newspress
·
22 Apr

HK Movers|HK Pharma Stocks Shined. Zai Lab Up 15%; HBM Up 10%; Remegen Up 9%; Alphamab And Wuxi Bio Up 5%.

Tiger Newspress
·
14 Apr

Chinese Biotech Stocks Outshine Tech Rally on Robust Earnings

Bloomberg
·
01 Apr

HK Pharma Stocks Shined. Wuxi Apptec And Alphamab Surged 11%, Wuxi Bio Soared 8%, Wuxi XDC Up 7%, Tigermed Up 5%.

Tiger Newspress
·
18 Mar

Pharmaron Beijing Expects Up to 16% Higher Attributable Net Profit for 2024

MT Newswires Live
·
22 Jan

BRIEF-Pharmaron Beijing Sees 2024 Net Profit Up 8-16% Y/Y

Reuters
·
21 Jan